Pharmacogenomic Progress Hinges On Strong Pharma Backing – Consultant
This article was originally published in The Gray Sheet
Executive Summary
Reference labs developing less costly "homebrew" tests could supplant diagnostic firms as the vehicle for commercializing pharmacogenomic tests, consultant Richard Barker told attendees at the IBC Dx/Rx Summit March 9 in Reston, Va